Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chronic Kidney Disease in Geriatric Primary Care in Andros Chronic Kidney Disease in Geriatric Primary Care in Andros Fani Athanasiou, Maria Mandaraka,

Similar presentations


Presentation on theme: "Chronic Kidney Disease in Geriatric Primary Care in Andros Chronic Kidney Disease in Geriatric Primary Care in Andros Fani Athanasiou, Maria Mandaraka,"— Presentation transcript:

1 Chronic Kidney Disease in Geriatric Primary Care in Andros Chronic Kidney Disease in Geriatric Primary Care in Andros Fani Athanasiou, Maria Mandaraka, Irene Ammolochitou, Ira Petsi, Georgios Mitrou 1 EOPYY Medical Unit, Chora Andros Objectives: Chronic kidney disease is a growing health concern of primary care. Family physicians must be equipped to care for this unique patient population. Hypertension and Diabetes Mellitus are the largest contributors to chronic kidney disease. Aim of the study was the prevalence of chronic kidney disease in geriatric patients in Andros island. 1 1

2 Methods: We studied a randomized population of elderly patients, above 60 years old, men and women. We kept a record of their age, their recent results of serum creatinine and their body weight. In order to estimate the level of chronic kidney insufficiency, we used the formula of Cockcroft-Gault. Presence of GFR ‹ 60 mL/min for at least 3 months, established the diagnosis of chronic kidney disease. 2

3 Results: 86% of the population, aged ± SD: 77 ± 6 (max: 87, min: 63) years old, has been detected with Chronic Kidney Disease. Average GFR ± SD estimated in those diagnosed: 38 ± 10 mL/min, (max: 57, min: 15) mL/min. 3

4 Conclusions: Regardless of the underlying etiology of the chronic kidney disease, the family physician can make a significant impact in slowing the progression of chronic kidney disease through strict blood pressure control, tight glycemic control, reduction in the degree of proteinuria and smoking cessation. Early screening and treatment of these complications can prevent the development of further sequelae and should not be delayed. Appropriate counseling and health maintenance is also needed for this patient population and should be given by the family physician involved in the patient’s care. 4

5 References O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. Oct 2007;18(10):2758-65. [Medline].[Medline] Matsushita K, Sang Y, Ballew S, et al. Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J Am Soc Nephrol. Aug 21, 2014;[Medline].[Medline] Laidman J. Coronary artery calcium best predicts CVD in CKD patients. Medscape Medical News [serial online]. August 22, 2014;Accessed August 25, 2014. Available at http://www.medscape.com/viewarticle/830314.http://www.medscape.com/viewarticle/830314 Lameire N, Van Biesen W. The initiation of renal-replacement therapy--just-in-time delivery. N Engl J Med. Aug 12 2010;363(7):678-80. [Medline].[Medline] [Guideline] Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. Jul 15 2003;139(2):137-47. [Medline].[Medline] Waknine Y. Kidney Disease Classification to Include Albuminuria Medscape Medical News. Dec 31 2012. Available at http://www.medscape.com/viewarticle/776940. Accessed Jan 9 2013.http://www.medscape.com/viewarticle/776940 [Guideline] KDIGO. Kidney Int Supp. Jan 2013;3(1):1-150. [Full Text].[Full Text] Thakar CV, Christianson A, Himmelfarb J, Leonard AC. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol. Nov 2011;6(11):2567-72. [Medline].[Medline] [Best Evidence] Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. Apr 2009;53(4):596-605. [Medline]. [Full Text].[Medline][Full Text] Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. Dec 12 2012;308(22):2349-60. [Medline]. [Full Text].[Medline][Full Text] de Boer IH. Chronic kidney disease—a challenge for all ages. JAMA. Dec 12 2012;308(22):2401-2. [Medline]. [Full Text].[Medline][Full Text] Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR. Population-Based Risk Assessment of APOL1 on Renal Disease. J Am Soc Nephrol. Nov 2011;22(11):2098-105. [Medline].[Medline] Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. Jun 15 2011;305(23):2432-9. [Medline]. [Full Text].[Medline][Full Text] Ellis JW, Chen MH, Foster MC, Liu CT, Larson MG, de Boer I, et al. Validated SNPs for eGFR and their associations with albuminuria. Hum Mol Genet. Jul 15 2012;21(14):3293-8. [Medline]. [Full Text].[Medline][Full Text] Pattaro C, Köttgen A, Teumer A, et al. Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet. 2012;8(3):e1002584. [Medline]. [Full Text].[Medline][Full Text] Nordfors L, Luttropp K, Carrero JJ, Witasp A, Stenvinkel P, Lindholm B, et al. Genetic studies in chronic kidney disease: basic concepts. J Nephrol. Mar-Apr 2012;25(2):141-9. [Medline].[Medline] Su SL, Lu KC, Lin YF, Hsu YJ, Lee PY, Yang HY, et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese population. J Renin Angiotensin Aldosterone Syst. Mar 2012;13(1):148-54. [Medline]. [Medline] Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014;9(1):e84943. [Medline]. [Full Text].[Medline][Full Text] Kidney Disease Statistics for the United States. National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC). Available at http://kidney.niddk.nih.gov/kudiseases/pubs/kustats/#17. Accessed September 5, 2012.http://kidney.niddk.nih.gov/kudiseases/pubs/kustats/#17 Centers for Disease Control and Prevention. Deaths and Mortality. Available at http://www.cdc.gov/nchs/fastats/deaths.htm.http://www.cdc.gov/nchs/fastats/deaths.htm Centers for Disease Control and Prevention. Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. MMWR Morb Mortal Wkly Rep. Mar 2 2007;56(8):161-5. [Medline]. [Full Text].[Medline][Full Text] [Best Evidence] Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O'Hare AM. White/black racial differences in risk of end-stage renal disease and death. Am J Med. Jul 2009;122(7):672-8. [Medline]. [Full Text].[Medline][Full Text] Schold JD, Srinivas TR, Braun WE, et al. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age. Clin Transplant. Sep 2011;25(5):721-30. [Medline].[Medline] Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, et al. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Kidney Int. Dec 2011;80(12):1339-43. [Medline].[Medline] Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, et al. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol. Apr 2009;4(4):812-9. [Medline]. [Full Text]. [Medline][Full Text] Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int. Sep 2005;68(3):914-24. [Medline].[Medline] United States Renal Data System. 2011 Annual Data Report. Available at http://www.usrds.org/adr.aspx. Accessed Sept 6, 2012.http://www.usrds.org/adr.aspx Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. Apr 20 2011;305(15):1553-9. [Medline].[Medline] Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. Dec 2 1999;341(23):1725-30. [Medline].[Medline] Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, et al. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol. Feb 2013;24(3):498-505. [Medline]. [Full Text].[Medline][Full Text] McNamara D. More frequent dialysis increases risk for complications. February 13, 2013. Medscape Medical News. Available at http://www.medscape.com/viewarticle/779265. Accessed August 29, 2013.http://www.medscape.com/viewarticle/779265 Sens F, Schott-Pethelaz AM, Labeeuw M, Colin C, Villar E. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int. Nov 2011;80(9):970-7. [Medline].[Medline] Wald R, Yan AT, Perl J, et al. Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis. BMC Nephrol. Jan 19 2012;13(1):3. [Medline].[Medline] Raphael KL, Wei G, Baird BC, Greene T, Beddhu S. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int. Feb 2011;79(3):356-62. [Medline].[Medline] Navaneethan SD, Schold JD, Arrigain S, et al. Low 25-Hydroxyvitamin D Levels and Mortality in Non-Dialysis-Dependent CKD. Am J Kidney Dis. Oct 2011;58(4):536-43. [Medline]. [Full Text].[Medline][Full Text] Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, et al. Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis. Oct 2012;60(4):567-75. [Medline]. [Full Text].[Medline][Full Text] Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ Jr, et al. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. Oct 2011;58(4):536-43. [Medline]. [Full Text].[Medline][Full Text] [Best Evidence] Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ. Validation of depression screening scales in patients with CKD. Am J Kidney Dis. Sep 2009;54(3):433-9. [Medline].[Medline] Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. Jul 5 2012;367(1):20-9. [Medline].[Medline] Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate?. Clin Chem. May 2002;48(5):699-707. [Medline].[Medline] Barclay L. ACP Guidelines: Do Not Screen Asymptomatic Adults for CKD. Medscape Medical News [serial online]. Oct 21 2013;Accessed Oct 29 2013. Available at http://www.medscape.com/viewarticle/812899.http://www.medscape.com/viewarticle/812899 Barclay L. CKD: ASN Recommends Screening, Rejects ACP Statement. Medscape Medical News [serial online]. Oct 23 2013;Accessed Oct 29 2013. Available at http://www.medscape.com/viewarticle/813082.http://www.medscape.com/viewarticle/813082


Download ppt "Chronic Kidney Disease in Geriatric Primary Care in Andros Chronic Kidney Disease in Geriatric Primary Care in Andros Fani Athanasiou, Maria Mandaraka,"

Similar presentations


Ads by Google